Info

Immusol is a private biotechnology company located in San Diego, California. The company currently employs approximately 50 employees, 90% of whom are focused on Research and Development. Immusol has built a management team with considerable combined experience in drug discovery and development. In addition, Immusol entered into a strategic alliance with Novartis in the area of Hepatitis C in December 2004, after completing a successful collaboration in oncology. Immusol's growing pipeline of internally-developed drug candidates includes a clinical-stage product for keloids and hypertrophic scars; a hyperproliferative disorder affecting the skin. Additionally, Immusol applies an integrated discovery and development program focused on novel treatments for cancer, viral infection and ophthalmology.